Investor Ideas Snapshot for NASDAQ Top Morning Movers; (OSIR), (CTCM), (AACC), (TIBX)
Ideas get bigger when you share them...
Visit: Osiris Therapeutics Inc.
New York, New York - March 6, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for March 6th, 2013.
Osiris Therapeutics Inc., (NASDAQ:OSIR) trading at $9.04 rose by $2.13 or 30.83% on a volume of 508,063 shares, making it today's top "morning mover" on the NASDAQ.
Shares of stem cell therapy developer Osiris Therapeutics Inc. rose earlier today after the company reported a jump in revenue from new surgical repair products.
Osiris said its product revenue increased more than 280 percent to $3.1 million in the fourth quarter of 2012, primarily from sales of Grafix, a wound healing implant designed to treat diabetic foot ulcers and other serious injuries. The company has begun promoting the device via a direct sales force in 10 major U.S. cities.
Osiris' experimental stem cell therapies include Prochymal, which is aimed at treating graft vs. host disease, a side effect of organ or bone marrow transplants. The Columbia, Md., company was developing Prochymal through a partnership with biotechnology company Genzyme. French drugmaker Sanofi later acquired Genzyme, and in February, Sanofi said it discontinued work on Prochymal
CTC Media Inc., (NASDAQ:CTCM) trading at $11.25 gained $1.21 or 12.05% on a volume of 1,453,899 shares.
Russian broadcaster CTC Media said on early today it would increase dividend payments by 21 percent this year after higher advertising sales helped to boost cash flow.
The company, which runs entertainment TV channels and production companies in Russia and other former Soviet states, plans to pay $0.63 per share, or up to $100 million in total, up from $0.52 per share or $82.2 million respectively in 2012.
It also declared a first-quarter dividend of $0.15 a share.
The company also said it expected its margin on the basis of operating income before depreciation and amortization at around 32 percent, or similar to the 2012 level when adjusted for impairment charges incurred last year.
Its fourth-quarter net profit came in at $64.9 million, compared to a $24.5 million year-ago loss, beating a $58.1 million analyst forecast.
Quarterly revenue rose 12 percent, year-on-year, to $264.2 million, above the $257.1 million forecast, while operating income totaled $103.8 million compared to the $94.55 million forecast.
Asset Acceptance Capital Corp., (NASDAQ:AACC) trading at $6.42 moved up $0.66 or 11.46% on a volume of 240,643 shares.
Debt collector Encore Capital Group Inc has agreed to buy Asset Acceptance Capital Corp for $200 million to strengthen its position in a highly fragmented industry.
Encore's offer of $6.50 per share represents a premium of 13 percent to Asset Acceptance's Tuesday closing price.
Its shareholders will have the option to receive their consideration in cash or Encore stock or a combination of both.
TIBCO Software Inc., (NASDAQ:TIBX) trading at $22.99 gained $1.99 or 9.48% on a high volume of 3,425,349 shares.
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com